Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

Single-protein Biomarkers Don’t Cut It – Translating Proteomics Episode 4

Key Takeaway: In the latest episode of 'Translating Proteomics,' hosts Drs. Parag Mallick and Andreas Huhmer discuss the limitations of single-protein biomarkers in biological research. They emphasize the need for multi-protein and multiomic approaches to enhance biomarker discovery. The episode highlights the challenges faced in identifying effective biomarkers and the importance of proteome-scale data.
Price reaction · baseline $2.7325 (2024-05-08T16:31:00.000Z) · hit during market hours · clean, no other NAUT news in the window
day 0 close · peak
-2.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Discussion on multi-protein biomarkers offers new research avenues.
  • Hosts are experienced scientists with a strong background in proteomics.
  • Emphasis on the need for proteome-scale data indicates a progressive approach.

CONCERNS & RISKS

  • Single-protein biomarkers are often insufficient for accurate biological indications.
  • Finding new biomarkers is challenging due to variability in biological systems.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

Applications of Proteomics
Nautilus Biotechnology
May 8, 2024
‘Translating Proteomics’ explores the science of proteomics and its growing impact on biological research, biomarker discovery , drug development , food and energy security, and a range of other timely topics. The goal of these conversations is to expose you to important issues in proteomics, deepen your love of science, and prompt you to question assumptions about what may be possible.
Your hosts are Drs. Parag Mallick and Andreas Huhmer of Nautilus Biotechnology. Parag is an Associate Professor at Stanford University whose lab performs systems biology studies that drive precision medicine approaches for cancer diagnosis and treatment. Andreas is a veteran scientist whose industry work has supported thousands of proteomics researchers by helping to bring the latest mass spec technologies into their labs.
Subscribe to Translating Proteomics on YouTube , Apple Podcasts , Spotify , or subscribe to our Translating Proteomics Newsletter to get the latest episodes delivered straight to your inbox.

Episode 4 – Single-protein Biomarkers Don’t Cut It

Protein biomarkers are proteins measured as indicators of biological processes. People often hope biomarkers will take the form of elevated or decreased amounts of single proteins, but few single protein measurements provide specific and sensitive indications of biological processes. In this episode of Translating Proteomics, Parag and Andreas discuss why it is difficult to find new biomarkers and describe how new techniques can enable the development of multi-protein, multi-time point, and even multiomic biomarkers that have more potential than any single protein measurement.
Chapters:
00:00 – What are biomarkers and why are they hard to find?
06:40 – What makes a good biomarker?
13:35 – How we can move beyond single-protein/single measurement biomarkers
Some key points of discussion:
• Biomarkers are difficult to find because of the methods we use to find them and because there is a ton of variability in natural biological systems
• Most proteins are biomarkers
• We need more proteome-scale data over space and time to find new biomarkers
Subscribe to the Translating Proteomics podcast on YouTube , Apple Podcasts , Spotify , or your favorite podcast outlet
Share this Article
Stay up-to-date on all things Nautilus
World-class articles, delivered weekly
MORE ARTICLES
Proteomics applications in medicine, basic biology, and beyond
Proteomics is being applied in many biological fields to unlock new discoveries and drive scientific advances.
Read more
White paper series: The proteomics revolution
This post contains white papers describing how developments in proteomics - led by the Nautilus platform - will improve healthcare.
Read more
Targeting healthcare disparities through the proteomics revolution (Part 1)
Learn how biases have led to inequities in healthcare and how researchers can rectify those inequities with better data.
Read more
Stay up-to-date on all things Nautilus

Subscribe to our Newsletter

Frequently Asked Questions

What are protein biomarkers?

Protein biomarkers are proteins measured as indicators of biological processes.

Why are single-protein biomarkers insufficient?

Single-protein biomarkers often lack specificity and sensitivity for biological indications.

What is discussed in Episode 4 of Translating Proteomics?

Episode 4 covers the challenges of finding new biomarkers and the potential of multi-protein approaches.

Who are the hosts of Translating Proteomics?

The hosts are Drs. Parag Mallick and Andreas Huhmer from Nautilus Biotechnology.

How can we improve biomarker discovery?

Improving biomarker discovery requires proteome-scale data over space and time.

Last updated: May 8, 2024